NL
BSX icon

NorthAvenue LLC’s Boston Scientific BSX Stock Holding History

NorthAvenue LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86K Hold
67
– – ﹤0.01% 200
2026
Q1 		$4.21K Hold
67
– – ﹤0.01% 161
2025
Q4 		$6.39K Buy
+67
New +$6.57K 0.01% 151

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

NorthAvenue LLC's BSX Position: Q2 2026 in Review

NorthAvenue LLC held its Boston Scientific (BSX) position steady in Q2 2026 at 67 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #200.

NorthAvenue LLC first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.39K in Q4 2025. 245 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • NorthAvenue LLC held 67 shares of Boston Scientific worth $2.86K as of Q2 2026.
  • NorthAvenue LLC left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of NorthAvenue LLC's portfolio in Q2 2026, its #200 holding.
  • NorthAvenue LLC first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • NorthAvenue LLC's Boston Scientific position peaked at $6.39K in Q4 2025.
  • 245 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on NorthAvenue LLC's 13F filing for Q2 2026, filed 21 Jul 2026.